PVR and Miyoshi myopathy: In this regard, strategies aimed to improve NK cell ability to kill MM cells, are based on the use of chemotherapeutic drugs that activate the DNA Damage Response (DDR) pathway and increase CD155 surface expression potentiating its transcription/expression [52,53,54,55,56].